title: The beneficial effects of pancreas transplant alone on diabetic nephropathy.
abstract: OBJECTIVE
  Pancreas transplant alone can be effective in significantly improving the quality of life of type 1 diabetic patients, and it can also eliminate acute diabetes complications, such as hypoglycemic and/or hyperglycemic episodes. The effects of pancreas transplant alone on long-term complications of diabetes, including nephropathy, are still not settled. We evaluated whether restoration of long-lasting normoglycemia by pancreas transplant alone might have beneficial action on diabetic nephropathy.
  
  
  METHODS
  A total of 32 type 1 diabetic patients were evaluated before and 1 year after successful pancreas transplant alone, together with 30 matched nontransplanted type 1 diabetic subjects. Several metabolic and kidney function parameters were measured, including plasma glucose, glycohemoglobin (A1C), C-peptide, plasma lipids, blood pressure, creatinine, creatinine clearance, and urinary protein excretion.
  
  
  RESULTS
  Pancreas transplant alone restored sustained normoglycemia, without exogenous insulin administration, and improved plasma lipid levels. Blood pressure decreased significantly. Creatinine concentrations and clearances did not differ before and after transplantation. Urinary protein excretion decreased significantly after pancreas transplant alone, with four microalbuminuric and three macroalbuminuric patients who became normoalbuminuric. None of these changes occurred in the nontransplanted group.
  
  
  CONCLUSIONS
  Successful pancreas transplant alone, through restoration of sustained normoglycemia, improves diabetic nephropathy in type 1 diabetic patients.
authors.affiliation: Department of Endocrinology and Metabolism, Metabolic Unit, Ospedale Cisanello, via Paradisa 2, 56100 Pisa, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Coppelli
authors.forename: Rosa
authors.initials: R
authors.lastname: Giannarelli
authors.forename: Fabio
authors.initials: F
authors.lastname: Vistoli
authors.forename: Stefano
authors.initials: S
authors.lastname: Del Prato
authors.forename: Gaetano
authors.initials: G
authors.lastname: Rizzo
authors.forename: Franco
authors.initials: F
authors.lastname: Mosca
authors.forename: Ugo
authors.initials: U
authors.lastname: Boggi
authors.forename: Piero
authors.initials: P
authors.lastname: Marchetti
mesh_terms: D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D002784:Cholesterol / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D016035:Pancreas Transplantation / Q000502:physiology*; D011507:Proteinuria; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D001786:Blood Glucose; D002096:C-Peptide; D014280:Triglycerides; D002784:Cholesterol